Archive | ARTES Biotechnology GmbH

Home / Archive

Vaccine development – ARTES

Wednesday 31st October 2018

By ARTES Biotechnology… Learn More >

ARTES and Minapharm join forces to package biopharma solutions

Monday 10th September 2018

By ARTES Biotechnology… Learn More >

Recombinant protein production – ARTES

Wednesday 8th August 2018

By ARTES Biotechnology… Learn More >

ARTES successfully completes EU-funded project PLURIVAX

Wednesday 18th April 2018

By ARTES Biotechnology… Learn More >

ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018

Monday 5th March 2018

By ARTES Biotechnology… Learn More >

Establishment of a yeast-based VLP platform for antigen presentation

Wednesday 21st February 2018

By ARTES Biotechnology… Learn More >

ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’

Monday 5th February 2018

By ARTES Biotechnology… Learn More >

ARTES seeking new collaborations at BioFIT 2017

Friday 24th November 2017

By ARTES Biotechnology… Learn More >

ARTES receives French CIR Research Tax Credit Accreditation

Tuesday 21st November 2017

By ARTES Biotechnology… Learn More >

EU patent grant for ARTES Biotechnology METAVAX®

Tuesday 22nd August 2017

By ARTES Biotechnology… Learn More >

ARTES White Paper outlines high-yield production process for secreted and active Invertase

Tuesday 15th August 2017

By ARTES Biotechnology… Learn More >

Cell line development based on efficient high-yield microbial expression platforms

Monday 3rd July 2017

By ARTES Biotechnology… Learn More >